미국의 치과용 멤브레인 및 골이식 대체물 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별 부문 예측(2025-2033년)

Market Size & Trends:

The U.S. dental membrane and bone graft substitutes market size was valued at USD 471.50 million in 2024 and is anticipated to reach USD 980.68 million by 2033, growing at a CAGR of 8.61% from 2025 to 2033. This growth is attributed to the rising prevalence of periodontal diseases, increasing demand for dental implants, and growing awareness of oral health and aesthetics.

Advancements in regenerative dental technologies, such as bioresorbable membranes, xenografts, and alloplastic grafts, are improving treatment outcomes, accelerating healing, and expanding the use of these materials in both restorative and cosmetic dental procedures. Additionally, an aging population with higher rates of tooth loss and bone resorption, and the increasing availability of minimally invasive procedures, are further boosting market growth.

The rising burden of dental disorders is a key factor driving the growth of the industry. Increasing incidences of conditions such as periodontal disease, tooth loss, and jawbone deterioration are leading to a greater need for regenerative dental procedures. These disorders often result in bone resorption and soft tissue loss, creating the necessity for bone graft substitutes and barrier membranes to restore oral structure and function. Furthermore, the growing demand for dental implants as a preferred tooth replacement solution has intensified the use of these biomaterials to ensure implant stability and successful bone regeneration. As awareness of oral health and access to advanced dental treatments expand, the demand for dental membranes and bone graft substitutes is expected to rise steadily across the country.

Regular dental visits are pivotal in driving the U.S. dental membrane and bone graft substitutes market, as they directly influence the need for preventive and restorative dental procedures. Many U.S. adults undergo routine dental check-ups annually, promoting early detection of periodontal disease, bone loss, and structural oral defects that often necessitate regenerative interventions using grafts and membranes. This emphasis on preventive care also enhances patient awareness and acceptance of advanced regenerative solutions, supporting sustained market demand. Additionally, unplanned or emergency dental visits, such as those for trauma, infections, or extractions, create immediate clinical needs for bone preservation and augmentation. The steady flow of routine and emergency cases maintains a consistent demand for dental membranes and bone graft substitutes, strengthening market growth across the country.

U.S. Dental Membrane And Bone Graft Substitutes Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. dental membrane and bone graft substitutes market report on the basis of product and application:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Bone Graft Substitutes (BGS)
  • Allograft
  • Demineralized Bone Matrix
  • Others
  • Autograft
  • Xenograft
  • Bovine Derived
  • Porcine Derived
  • Others
  • Synthetic
  • Hydroxyapatite (HA)
  • Tricalcium Phosphate (TCP)
  • Bioactive Glass
  • Others
• Dental Membranes and Soft Tissue Regeneration Materials
  • Resorbable Membranes
  • Bovine -derived collagen based
  • Porcine derived collagen based
  • Others
  • Non- Resorbable Membrane
  • Expanded PTFE (ePTFE)
  • Dense PTFE (dPTFE)
  • Titanium-Reinforced PTFE
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Ridge Augmentation
• Sinus Lift
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Socket Preservation
• Soft Tissue Regeneration
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity price analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dental Membrane And Bone Graft Substitutes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising burden of dental disorders
    • 3.2.1.2. Development of synthetic bone grafts
    • 3.2.1.3. Growing demand for aesthetic and restorative dental procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of dental treatments
    • 3.2.2.2. Potential risks and complications associated with dental procedures
  • 3.2.3. Market Challenge Analysis
    • 3.2.3.1. Regulatory and approval complexities
    • 3.2.3.2. Economic and currency exchange risks
  • 3.2.4. Market Opportunity Analysis
    • 3.2.4.1. Increasing number of clinical trials
    • 3.2.4.2. Growing development & approvals of resorbable membranes
    • 3.2.4.3. Expansion into synthetic membrane
    • 3.2.4.4. Strategic partnerships & investment to enhance market presence
    • 3.2.4.5. Expansion opportunities in emerging economies
    • 3.2.4.6. Increasing demand for composite bone grafts
    • 3.2.4.7. Growing focus on 3D printed and custom grafts
• 3.3. U.S. Dental Membrane And Bone Graft Substitutes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dental Membrane And Bone Graft Substitutes Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Dental Membrane And Bone Graft Substitutes Market Product Movement Analysis
• 4.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
• 4.4. Bone Graft Substitutes (BGS)
  • 4.4.1. Bone graft substitutes (BGS) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. Allograft
      • 4.4.1.1.1. Allograft market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.1.1.1. Demineralized Bone Matrix
          • 4.4.1.1.1.1.1. Demineralized bone matrix market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.1.1.2. Others
          • 4.4.1.1.1.2.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. Autograft
      • 4.4.1.2.1. Autograft market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.3. Xenograft
      • 4.4.1.3.1. Xenograft market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.1. Bovine Derived
          • 4.4.1.3.1.1.1. Bovine derived market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.2. Porcine Derived
          • 4.4.1.3.1.2.1. Porcine derived market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.3. Others
          • 4.4.1.3.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.4. Synthetic
      • 4.4.1.4.1. Synthetic market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.1. Hydroxyapatite (HA)
          • 4.4.1.4.1.1.1. Hydroxyapatite (HA) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.2. Tricalcium Phosphate (TCP)
          • 4.4.1.4.1.2.1. Tricalcium phosphate (TCP) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.3. Bioactive Glass
          • 4.4.1.4.1.3.1. Bioactive glass market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.4. Others
          • 4.4.1.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Dental Membranes and Soft Tissue Regeneration Materials
  • 4.5.1. Dental membranes and soft tissue regeneration materials market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.1. Resorbable membranes
      • 4.5.1.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.1. Bovine -derived collagen based
          • 4.5.1.1.1.1.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.2. Porcine derived collagen based
          • 4.5.1.1.1.2.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.3. Others
          • 4.5.1.1.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.2. Non resorbable membranes
      • 4.5.1.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.1. Expanded PTFE (ePTFE)
          • 4.5.1.2.1.1.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.2. Dense PTFE (dPTFE)
          • 4.5.1.2.1.2.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.3. Titanium-Reinforced PTFE
          • 4.5.1.2.1.3.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Dental Membrane And Bone Graft Substitutes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Dental Membrane And Bone Graft Substitutes Market Application Movement Analysis
• 5.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Ridge Augmentation
  • 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Sinus Lift
  • 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Periodontal Defect Regeneration
  • 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.7. Implant Bone Regeneration
  • 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.8. Socket Preservation
  • 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.9. Soft Tissue Regeneration
  • 5.9.1. Soft tissue regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
• 6.3. Vendor Landscape
  • 6.3.1. Key company market share analysis, 2024
  • 6.3.2. Dentsply Sirona
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Usage benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Bioteck S.p.A.
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Usage benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Institut Straumann AG
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Usage benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Maxigen Biotech Inc.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Usage benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Nobel Biocare Services AG (Envista)
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Usage benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Geistlich Pharma North America, Inc.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Usage benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. ZimVie Inc.
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Usage benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. NovaBone (Halma)
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Usage benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Regenity
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Usage benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Medtronic
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Usage benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. BioHorizons
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Usage benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. Curasan, Inc.
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Usage benchmarking
    • 6.3.13.4. Strategic initiatives
  • 6.3.14. DentiumUSA
    • 6.3.14.1. Company overview
    • 6.3.14.2. Financial performance
    • 6.3.14.3. Usage benchmarking
    • 6.3.14.4. Strategic initiatives
  • 6.3.15. Unicare Biomedical, Inc.
    • 6.3.15.1. Company overview
    • 6.3.15.2. Financial performance
    • 6.3.15.3. Usage benchmarking
    • 6.3.15.4. Strategic initiatives
  • 6.3.16. Neoss
    • 6.3.16.1. Company overview
    • 6.3.16.2. Financial performance
    • 6.3.16.3. Usage benchmarking
    • 6.3.16.4. Strategic initiatives